Treatment options in end-stage heart failure: Where to go from here?

Netherlands Heart Journal

Volumn 20, Issue 4, 2012, Pages 167-175

  Haeck, M L A ^a   Hoogslag, G E ^a   Rodrigo, S F ^a   Atsma, D E ^a   Klautz, R J ^a   van der Wall, E E ^a   Schalij, M J ^a   Verwey, H F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Heart failure; Heart failure program; Mechanical cardiac support; Resynchronization therapy; Surgery

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BIVENTRICULAR ASSIST DEVICE; CARDIAC RESYNCHRONIZATION THERAPY; CORONARY ARTERY BYPASS GRAFT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LIFESTYLE MODIFICATION; MITRAL VALVE REGURGITATION; PATIENT CARE; QUALITY OF LIFE; REVIEW; RIGHT VENTRICULAR ASSIST DEVICE; SURVIVAL;

EID: 84859651605     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-011-0211-4     Document Type: Review

References (42)

1. Vaartjes I, Reitsma JB, de Bruin A, et al. Verschillen tussen mannen en vrouwen in sterftekans na een eerste ziekenhuisopname vanwege hartfalen. Nederlandse Hartstichting; 2008.
2. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347(18):1397-402.
3. Hershberger RE, Nauman D, Walker TL, et al. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail. 2003;9(3):180-7.
4. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J. 2008;29(19):2388-442.
5. de Jonge N, Kirkels JH, Klopping C, et al. Guidelines for heart transplantation. Neth Heart J. 2008;16(3):79-87.
6. Copeland JG. Advanced medical therapy does not render heart transplantation obsolete for ambulatory end-stage heart failure patients: a debate. J Heart Lung Transplant. 2001;20(7):725-8.
7. Baker DW, Jones R, Hodges J, et al. Management of heart failure: III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 1994;272(19):1528-34.
8. Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364(17):1607-16.
9. Gaudron P, Eilles C, Kugler I, et al. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation. 1993;87(3):755-63.
10. Di Donato M, Sabatier M, Dor V, et al. Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J Thorac Cardiovasc Surg. 2001;121(1):91-6.
11. Eisen HJ. Surgical ventricular reconstruction for heart failure. N Engl J Med. 2009;360(17):1781-4.
12. Athanasuleas CL, Buckberg GD, Stanley AWH, et al. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol. 2004;44(7):1439-45.
13. Jones RH, Velazquez EJ, Michler RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360(17):1705-17.
14. Mann DL, Acker MA, Jessup M, et al. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Ann Thorac Surg. 2007;84(4):1226-35.
15. Starling RC, Jessup M, Oh JK, et al. Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn Clinical Trial. Ann Thorac Surg. 2007;84(4):1236-42.
16. Trichon BH, Felker GM, Shaw LK, et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91(5):538-43.
17. Bax JJ, Braun J, Somer ST, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation. 2004;110 (11_suppl_1):II-103.
18. Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: A report from the Italian network on congestive heart failure. Am Heart J. 2002;143(3):398-405.
19. Littmann L, Symanski JD. Hemodynamic implications of left bundle branch block. J Electrocardiol. 2000;33(Supplement 1):115-21.
20. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361(14):1329-38.
21. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52(23):1834-43.
22. Dickstein K, Vardas PE, Auricchio A, et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure. Eur J Heart Fail. 2010;12(11):1143-53.
23. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA. 2003;289(20):2685-94.
24. Lindenfeld J, Feldman AM, Saxon L, et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation. 2007;115(2):204-12.
25. Ypenburg C, van Bommel RJ, Borleffs CJW, et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol. 2009;53(6):483-90.
26. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med. 1998;339(21):1522-33.
27. Christiansen S, Klocke A, Autschbach R. Past, present, and future of long-term mechanical cardiac support in adults. J Card Surg. 2008;23(6):664-76.
28. Oosterom A, de Jonge N, Kirkels JH, et al. End-stage heart failure and mechanical circulatory support: feasibility of discharge from hospital. Neth Heart J. 2007;15(2):45-50.
29. Oz MC, Goldstein DJ, Rose EA. Preperitoneal placement of Ventricular Assist Devices: an illustrated stepwise approach. J Card Surg. 1995;10(4):288-94.
30. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow Left Ventricular Assist Device. N Engl J Med. 2009;361(23):2241-51.
31. Wieselthaler GM, O'Driscoll G, Jansz P, et al. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant. 2010;29(11):1218-25.
32. Esmore D, Kaye D, Spratt P, et al. A prospective, multicenter trial of the VentrAssist Left Ventricular Assist Device for bridge to transplant: safety and efficacy. J Heart Lung Transplant. 2008;27 (6):579-88.
33. Frazier OH, Rose EA, Macmanus Q, et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg. 1992;53(6):1080-90.
34. Pennington DG, McBride LR, Peigh PS, et al. Eight years' experience with bridging to cardiac transplantation. J Thorac Cardiovasc Surg. 1994;107(2):472-81.
35. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9):885-96.
36. Frazier MD, Benedict MD, Radovancevic MD, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996;62(3):675-82.
37. Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after Left Ventricular Assist Device implantation in patients with chronic heart failure. Circulation. 1998;98 (22):2383-9.
38. Simon MA, Kormos RL, Murali S, et al. Myocardial recovery using Ventricular Assist Devices: prevalence, clinical characteristics, and outcomes. Circulation. 2005;112(9_suppl):I-32.
39. Oosterom L, de Jonge N, Kirkels J, et al. Left ventricular assist device as a bridge to recovery in a young woman admitted with peripartum cardiomyopathy. Neth Heart J. 2008;16(12):426-8.
40. Pruijsten RV, de Jonge N, Kirkels JH, et al. Left ventricular assist device: a functional comparison with heart transplantation. Neth Heart J. 2008;16(2):41-6.
41. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a Left Ventricular Assist Device for end-stage heart failure. N Engl J Med. 2001;345(20):1435-43.
42. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID trial. J Am Coll Cardiol. 2007;50(8):741-7.